Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$22.5M Sell
414,209
-29,378
-7% -$1.91M 0.19% 124
2015
Q2
$29.8M Sell
443,587
-5,436
-1% -$355K 0.25% 114
2015
Q1
$26.3M Buy
449,023
+3,302
+0.7% +$199K 0.22% 122
2014
Q4
$29.2M Sell
445,721
-38,347
-8% -$2.42M 0.25% 120
2014
Q3
$28M Buy
484,068
+6,074
+1% +$337K 0.26% 123
2014
Q2
$27M Buy
477,994
+177,059
+59% +$9.29M 0.25% 124
2014
Q1
$15.5M Sell
300,935
-104,877
-26% -$5.3M 0.22% 130
2013
Q4
$21.4M Buy
405,812
+94,549
+30% +$4.65M 0.32% 112
2013
Q3
$13.9M Sell
311,263
-30,801
-9% -$1.37M 0.25% 131
2013
Q2
$14.1M Buy
+342,064
New +$15M 0.26% 121

Other funds holding ABBV

City National Bank's ABBV Position: Q3 2015 in Review

City National Bank reduced its AbbVie (ABBV) stake by 6.6% in Q3 2015, selling an estimated $1.91M and leaving 414,209 shares worth $22.5M. The position accounts for 0.19% of the portfolio, ranked #124.

City National Bank first reported a position in ABBV in Q2 2013 and has held it in 10 quarters since. The position peaked at $29.8M in Q2 2015. 1,604 funds tracked by Wall St. Rank hold ABBV as of Q3 2015.

  • City National Bank held 414,209 shares of AbbVie worth $22.5M as of Q3 2015.
  • City National Bank sold 29,378 AbbVie shares in Q3 2015, an estimated $1.91M.
  • AbbVie made up 0.19% of City National Bank's portfolio in Q3 2015, its #124 holding.
  • City National Bank first reported a position in AbbVie in Q2 2013 and has held it in 10 quarters since.
  • City National Bank's AbbVie position peaked at $29.8M in Q2 2015.
  • 1,604 funds tracked by Wall St. Rank held AbbVie as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.